Back to top

Novonesis (0Q4U) Receives a Buy from Morgan Stanley

Morgan Stanley analyst Lisa De Neve maintained a Buy rating on Novonesis today and set a price target of DKK520.00. According to TipRanks, De Neve ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)